Advanced Medical Optics viscosurgical device receives FDA approval
Advanced Medical Optics (AMO) announced that the FDA has granted premarket approval of a clear dispersive ophthalmic viscosurgical device (OVD) (Healon D) for use as a surgical aid in cataract extraction, IOL implantation, corneal transplant, and glaucoma filtration surgery.
Key Points
Santa Ana, CA-Advanced Medical Optics (AMO) announced that the FDA has granted premarket approval of a clear dispersive ophthalmic viscosurgical device (OVD) (Healon D) for use as a surgical aid in cataract extraction, IOL implantation, corneal transplant, and glaucoma filtration surgery.
Due to its low molecular weight, the OVD coats the cornea and remains in place throughout the entire surgical process. The latex-free OVD has a lower viscosity, providing ideal lubrication of IOL insertion systems, according to the company.
The FDA approval of the OVD also allows AMO to introduce two new dual-pack ophthalmic viscosurgical systems that contain the OVD as part of convenient combination packs.
